Pharmaceuticals, Biotechnology and Life Sciences
Current XanaMIA pivotal phase 2/3 trial on track for interim analysis in January 2026 and final results late 2026 with…
Oral semaglutide (Rybelsus®) is now the first and only oral GLP-1 RA approved for type 2 diabetes, with proven cardiovascular…
Revised label allows treatment of DEB patients from birth VYJUVEK can now be applied by patients and caregivers PITTSBURGH, Sept.…
NEW YORK, Sept. 14, 2025 (GLOBE NEWSWIRE) — Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory…
Clinicians’ Tested Choice Best Testosterone Booster Supplements to increase testosterone and muscle gain for men: Medically Reviewed and Endorsed by…
Performer 8 is a non-prescription male enhancement pills, herbal performance enhancer ED pill for men formulated to support natural stamina,…
WILMETTE, Ill., Sept. 14, 2025 (GLOBE NEWSWIRE) — Monopar Therapeutics Inc. (“Monopar” or the “Company”) (Nasdaq: MNPR), a clinical-stage biopharmaceutical…
TORONTO, Sept. 12, 2025 (GLOBE NEWSWIRE) — Avicanna Inc. (“Avicanna” or the “Company”) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN), a…
— HUTCHMED will host in-person presentation and online webinar on Friday, October 31 —HONG KONG and SHANGHAI and FLORHAM PARK,…
SEATTLE and VANCOUVER, British Columbia, Sept. 11, 2025 (GLOBE NEWSWIRE) — Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage specialty…